Regarding the evidence-based use of micronized progesterone
Obstetrics, Gynecology and Reproduction
; 14(3):374-383, 2020.
Article
in Russian
| EMBASE | ID: covidwho-903106
ABSTRACT
An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by us, displays signs of prejudiced data manipulation and may disorient practitioners. In this Letter we provide objective information on accumulated data regarding gestagenes efficacy and safety. We invoke healthcare professionals to make decisions deserving independent primary source trust presented by original scientific papers published in peer-reviewed journals, clinical recommendations proposed by professional medical communities as well as treatment standards and protocols.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Russian
Journal:
Obstetrics, Gynecology and Reproduction
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS